Looking To Buy Novo Integrated Sciences Inc. (NVOS)? Read This First


Novo Integrated Sciences Inc. (NASDAQ:NVOS) saw an upside of 5.74% to close Monday at $0.12 after subtracting $0.0 on the day. The 5-day average trading volume is 16,566,400 shares of the company’s common stock. It has gained $0.1318 in the past week and touched a new high 1 time within the past 5 days. An average of 11,510,830 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 4,659,602.

NVOS’s 1-month performance is -44.04% or -$0.0775 on its low of $0.1007 reached on 01/19/23. The company’s shares have touched a 52-week low of $0.10 and high of $3.32, with the stock’s rally to the 52-week high happening on 01/09/23. YTD, NVOS has lost -38.64% or -$0.0777 and has reached a new high 2 times. However, the current price is down -96.28% from the 52-week high price.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


Valuation Metrics

NVOS stock has a beta of -0.20. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 0.29 while the price-to-book (PB) in the most recent quarter is 0.08.

Novo Integrated Sciences Inc.’s quick ratio for the recent period was 1.50, with the current ratio over the same period at 1.60. In terms of profitability, the gross margin trailing 12 months is 26.00%. The firm’s gross profit as reported stood at $3.82 million against revenue of $9.3 million.

Earnings Surprise

Net income and sales went up compared to those figures reported in the previous quarter. Net income grew 64.83% to -$3.81 million, while revenue of -$4.81 million was -26.25% off the previous quarter. EBITDA for the quarter stood at more than $1.81 million. NVOS stock balance sheet for the recent quarter shows that total liabilities totaled 27.36 million, with total debt at $21.29 million. Shareholders hold equity totaling $31.02 million.

Let’s look briefly at Novo Integrated Sciences Inc. (NVOS) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 23 January was 34.62% to suggest the stock is trending Neutral, with historical volatility in this time period at 114.27%.

The stock’s 5-day moving average is $0.1154, reflecting a -6.16% or -$0.0081 change from its current price. NVOS is currently trading -44.46% above its 20-day SMA, -92.95% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -50.84% and SMA200 by-94.21%.

Stochastic %K and %D was 6.25% and 4.38% and the average true range (ATR) pointed at 0.0284. The RSI (14) points at 32.36%, while the 14-day stochastic is at 9.90% with the period’s ATR at 0.0306. The stock’s 9-day MACD Oscillator is pointing at -0.0149 and -0.0283 on the 14-day charts.

Analyst Ratings


Please enter your comment!
Please enter your name here